 Pancreatic cystic lesions<symptom> ( PCLs) are increasingly diagnosed with the advent of cross-sectional imaging and its incidence was as high as 13.7 % on MRI in asymptomatic individuals , which increased with age or obesity ( 1). Most of those asymptomatic PCLs are not malignant at the time of diagnosis but require surveillance , which can pose physical and psychological burden to those individuals under surveillance as well as the burden of medical costs. Although several guidelines for management of PCLs have been published , they are not necessarily evidence-based. This article is protected by copyright. All rights reserved.